DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1DACOGEN
02 10DECITABINE
03 1RANITIDINE HYDROCHLORIDE
04 1VITRASE
05 1ZANTAC
06 1ZEVALIN
01 119090
02 121640
03 121790
04 179076
05 1125019
06 1202969
07 1203131
08 1203475
09 1205539
10 1206033
11 1208601
12 1209056
13 1210756
14 1210984
15 1212265
01 15No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 203131
Country : US
Patented : No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 203475
Country : US
Patented : No
Drug : VITRASE
Dosage Form : INJECTABLE; INJECTION
Application Number : 21640
Country : US
Patented : No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 206033
Country : US
Patented : No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 208601
Country : US
Patented : No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 205539
Country : US
Patented : No
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 210756
Country : US
Patented : No
Drug : DACOGEN
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 21790
Country : US
Patented : No
Drug : ZANTAC
Dosage Form : INJECTABLE; INJECTION
Application Number : 19090
Country : US
Patented : No
Drug : ZEVALIN
Dosage Form : INJECTABLE; INJECTION
Application Number : 125019
Country : US
Patented : No
LOOKING FOR A SUPPLIER?